Ophthalmology · Kent, OH
NPI
1457541104
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
2013 State Route 59
Kent, OH, 44240
Phone (330) 678-0201
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
2,207 services
Medicare patients, 2024
646
Average age 75
Drug cost, 2024
$823K
5,740 prescriptions
Company payments, 2025
$3,842
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew C Willett was code 99214 (office e&m - established), 677 times for 372 patients. In total Matthew C Willett billed 2,207 services in 32 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 677 | 372 | $91.01 | $62K |
| 66984 Cataract Surgery | Facility | 330 | 198 | $379.59 | $125K |
| 92136 Ultrasound - Nonspecific | Office | 232 | 232 | $33.01 | $7,659 |
| 99204 Office E&M - New | Office | 202 | 202 | $113.25 | $23K |
| 92133 Computerized Ophthalmic Imaging | Office | 145 | 144 | $24.86 | $3,604 |
| 92083 Vision, Hearing, and Speech Services | Office | 127 | 122 | $43.36 | $5,507 |
| 92020 Ophthalmological E&M | Office | 87 | 82 | $20.56 | $1,789 |
| 99213 Office E&M - Established | Office | 83 | 70 | $57.27 | $4,753 |
| 66821 Cataract Surgery | Office | 78 | 76 | $299.75 | $23K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 47 | 32 | $195.17 | $9,173 |
| 66174 Fluid Flow and Drainage of Eye (Any Method) | Facility | 33 | 21 | $487.55 | $16K |
| 92014 Ophthalmological E&M | Office | 28 | 28 | $82.95 | $2,323 |
| 92134 Computerized Ophthalmic Imaging | Office | 23 | 20 | $29.08 | $669 |
| 76514 Ultrasound - Nonspecific | Office | 21 | 21 | $8.18 | $172 |
| 66761 Fluid Flow and Drainage of Eye (Any Method) | Office | 19 | 17 | $324.69 | $6,169 |
By year: 2022 $338K for 3,255 services; 2023 $299K for 2,583 services; 2024 $311K for 2,207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew C Willett prescribed most often to Medicare patients was Prednisolone Acetate, with 647 prescriptions and refills. In total Matthew C Willett wrote 5,740 Medicare prescriptions that cost $823K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 647 | 920 | 458 | $27K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 595 | 1,362 | 182 | $9,505 |
| Latanoprost Generic | 574 | 1,380 | 194 | $7,967 |
| Brimonidine Tartrate Generic | 530 | 1,240 | 172 | $67K |
| Timolol Maleate Generic | 410 | 1,087 | 131 | $5,922 |
| Moxifloxacin Moxifloxacin Hcl | 390 | 392 | 258 | $11K |
| Diclofenac Sodium Generic | 346 | 459 | 229 | $3,685 |
| Lumigan Bimatoprost | 322 | 680 | 103 | $177K |
| Dorzolamide Hcl Generic | 222 | 484 | 74 | $5,598 |
| Rhopressa Netarsudil Mesylate | 199 | 375 | 67 | $116K |
| Pilocarpine Hcl Generic | 185 | 469 | 96 | $11K |
| Travoprost Generic | 155 | 307 | 44 | $20K |
| Vyzulta Latanoprostene Bunod | 150 | 296 | 54 | $87K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 145 | 325 | 49 | $24K |
| Brinzolamide Generic | 143 | 320 | 42 | $22K |
Brand drugs: 2,109 claims; generic drugs: 3,631 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew C Willett $3,842 ($3,842 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sight Sciences, Inc. with $2,728.
| Company | Payments | Amount |
|---|---|---|
| Sight Sciences, Inc. SGHT | 7 | $2,728 |
| Alcon Vision LLC ALC | 16 | $453 |
| Harrow Eye, LLC | 5 | $200 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $132 |
| Abbvie Inc. ABBV | 5 | $93.17 |
| Glaukos Corporation GKOS | 4 | $88.31 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $50.23 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $40.96 |
| RxSight Inc RXST | 1 | $21.61 |
| Amgen Inc. AMGN | 1 | $18.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.